FDA NDC Directory · JSON-LD · Markdown

SEMGLEE

NDC 83257-012 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameinsulin glargine-yfgn
Labeler / ManufacturerBiocon Biologics Inc.
Marketing categoryBiologic License Application · App BLA761201
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsINSULIN GLARGINE (100 [iU]/mL)
Marketing started20230728
Marketing ended20270531
Package count2

External sources

Source: openFDA. Public-domain (CC0).